Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Understanding the economic and healthcare burden of metabolic dysfunction-associated steatohepatitis: a real-world claims data analysis from Germany
Frank Tacke
,
Yestle Kim
,
Jennifer S Haas
,
Melinda J Daumont
,
Christopher Maas
,
John O'Donnell
, and
Jörn M Schattenberg
Journal of Comparative Effectiveness Research
22 Jul 2026
Clinical effectiveness of a digitally delivered balance program for older adults: a nonrandomized controlled trial
Folasade Phillips
,
Sandhya Yadav
,
Cynthia Castro Sweet
,
Rachel NS Foster Kirk
,
Mindy Hong
,
Samuel Mink
, and
Jeffrey Krauss
Journal of Comparative Effectiveness Research
21 Jul 2026
Can we trust AI-generated RWD? A systematic validation approach in prostate cancer
The Evidence Base
22 Jul 2026
HTA Coordination Group issues guidance on AI use in Joint Clinical Assessment dossier preparation
The Evidence Base
21 Jul 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
22 Jul 2026
Can we trust AI-generated RWD? A systematic validation approach in prostate cancer
21 Jul 2026
Building readiness for HTA through horizon scanning and real-world evidence: Insights from the RWE4Decisions webinar
21 Jul 2026
From claims to commercial strategy: Finding actionable insights in rare disease data
21 Jul 2026
HTA Coordination Group issues guidance on AI use in Joint Clinical Assessment dossier preparation
21 Jul 2026
Building readiness for HTA through horizon scanning and real-world evidence: Insights from the RWE4Decisions webinar
20 Jul 2026
Evidence generation shouldn't end with publication: Why every HEOR and RWE publication needs a plain language strategy
15 Jul 2026
Following the patient journey: How connected data and evolving methods are reshaping real-world evidence
15 Jul 2026
ISPOR Special Task Force introduces IMPACT framework for value-based healthcare implementation
14 Jul 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in June 2026
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
22 Jul 2026
Can we trust AI-generated RWD? A systematic validation approach in prostate cancer
21 Jul 2026
HTA Coordination Group issues guidance on AI use in Joint Clinical Assessment dossier preparation
21 Jul 2026
Building readiness for HTA through horizon scanning and real-world evidence: Insights from the RWE4Decisions webinar
21 Jul 2026
From claims to commercial strategy: Finding actionable insights in rare disease data
.png)
.png)
